what glp 1 is approved for weight loss Indications GLP-1/GIP RA Summary Sheet and Beyond! New GLP-1 Pill Foundayo (Orforglipron)

Gastric inhibitory polypeptide release after oral glucose: Relationship to glucose intolerance, diabetes mellitus, and obesity

Acute kidney injury was reported in GLP-1 RA trials and was believed to be secondary to volume contraction due to GI symptoms or concomitant use of drugs working on the reninangiotensin pathway [69]

Researchers from the German Center for Diabetes Research (DZD) and Helmholtz Munich, in collaboration with a colleague from the University of Santiago de Compostela in Spain, describe the development of incretin-based pharmacotherapy from its beginnings to the discovery of polyagonists

Mobilization of fatty acids containing PUFA moieties can further increase susceptibility to lipid peroxidation [69, 70]